You searched for viral vector - Page 4 of 53

Best in Biotech 16 Apr 2025

HIV innovation: Six companies developing new treatments in 2025

…viral DNA. EBT-101 is currently in a phase 1/2 clinical trial involving individuals living with HIV who are on stable antiretroviral therapy (ART). In May 2024, Excision reported that the…

April 16, 2025 - 9 minutesmins - By Jules Adam

Best in Biotech 2 Jul 2024

Swiss biotech going strong in 2024: 18 companies to put on your radar

…of these production processes, NewBiologix aims to make gene therapy more accessible and cost-effective. NewBiologix develops cell lines and bioinformatics platforms to enhance the production of viral vectors. rAAV vectors…

July 2, 2024 - 20 minutesmins - By Jules Adam

News and Trends 19 Feb 2020

Belgian Biotech Raises €50M to Make Gene Therapy Manufacturing Cheaper

An equity investment worth up to €50M will push to market Univercells’ manufacturing technology, which is designed to reduce the costs of viral vector production for gene therapies. The investment…

February 19, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 18 Jul 2016

How did we increase the online traffic of this Biotech by 289%?

…production of lentiviral vectors. Thanks to our solution, we helped brought more visitors to their website. The campaign was a great success, leading this company increase its sales and close…

July 18, 2016 - 3 minutesmins - By Joachim Eeckhout

Miquel Vila Perelló gene therapy SpliceBio

Interview 28 Nov 2022

Breaking barriers to gene therapies for childhood rare diseases

…therapies consist of a viral vector that carries a therapeutic gene into the patient and lets the patient produce healthy versions of a dysfunctional gene. However, there are limits to…

November 28, 2022 - 5 minutesmins - By Jonathan Smith

Startup Scout 21 Nov 2022

Osivax is designing future-proof influenza and Covid vaccines

…as they have some advantages over viral vector vaccines and messenger RNA (mRNA) vaccines. For example, some viral vector vaccines aren’t well suited to repeated immunization, and mRNA vaccines tend…

November 21, 2022 - 5 minutesmins - By Jonathan Smith

Biologics testing: The right time to move to new standards?

…sequencing (NGS)-based assays. Therapeutic biologics cover a wide range of modalities, including monoclonal antibodies, vaccines, recombinant proteins, viral vectors, and cell and gene therapies. Quality control procedures must be performed…

April 30, 2024 - 6 minutesmins - By Ute Boronowsky

Best in Biotech 24 Apr 2025

21 UK biotech companies you should know about

…response to the viral vector limits patient access and often precludes multiple dosing. The company’s proprietary DeliverEX platform enables it to load exosomes with diverse drug cargos, leverage the unique…

April 24, 2025 - 27 minutesmins - By Willow Shah-Neville

News and Trends 20 Jul 2023

Seven pharma companies form alliance to prepare for future pandemics

…Amgen, Gilead, Johnson & Johnson, Novartis, Roche and Takeda. The INTREPID alliance creation is in support of the 100 Days Mission, which seeks to have 25 antiviral therapies for viral…

July 20, 2023 - 5 minutesmins - By Jim Cornall

News and Trends 5 Feb 2018

New Antiviral for RSV Lung Infections Shows Promise in Phase IIa

ReViral’s candidate RV521 showed its potential for the treatment of respiratory syncytial virus (RSV) infections by reducing viral load and mucus levels. London-based biotech ReViral discovers and develops antiviral drugs,…

February 5, 2018 - 3 minutesmins - By Alex Dale

Best in Biotech 8 Mar 2023

5 female-led biotech startups making waves

…use associated viral vectors (AAV) or other viral vectors to deliver genetic material. Instead, this female-led biotech company works on developing non-viral gene therapy alternatives using synthetic biology and engineered…

March 8, 2023 - 6 minutesmins - By Willow Shah-Neville

News and Trends 28 Jan 2020

A Future Gene Therapy Could Be Delivered in Tiny ‘Nanocontainers’

…than conventional gene therapies. The majority of gene therapies in use today are delivered to the DNA of target cells using viral vectors. While efficient at their job, viral vectors…

January 28, 2020 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

HIV innovation: Six companies developing new treatments in 2025

Swiss biotech going strong in 2024: 18 companies to put on your radar

Belgian Biotech Raises €50M to Make Gene Therapy Manufacturing Cheaper

How did we increase the online traffic of this Biotech by 289%?

Breaking barriers to gene therapies for childhood rare diseases

Osivax is designing future-proof influenza and Covid vaccines

Biologics testing: The right time to move to new standards?

21 UK biotech companies you should know about

Seven pharma companies form alliance to prepare for future pandemics

New Antiviral for RSV Lung Infections Shows Promise in Phase IIa

5 female-led biotech startups making waves

A Future Gene Therapy Could Be Delivered in Tiny ‘Nanocontainers’

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!